Nafithromycin

 Source:  PIB Context: In a ground breaking step for India’s biotechnology sector, Union Minister Dr. Jitendra Singh formally launched the first indigenous antibiotic “Nafithromycin” for resistant infections. About Nafithromycin: Purpose: Targets Community-Acquired Bacterial Pneumonia (CABP) caused by drug-resistant bacteria, addressing Antimicrobial Resistance (AMR). Developed By: Wockhardt with support from the Biotechnology Industry Research Assistance Council …

Central Drugs Standard Control Organisation (CDSCO)

Facts for Prelims (FFP) Source: LM Context: The Central Drugs Standard Control Organisation (CDSCO) will now exclusively have the authority to issue manufacturing licenses for new drugs intended for export, removing this power from state governments. This change, effective from May 15, 2024, mandates that all applications for No Objection Certificates (NOCs) for export purposes …

Cholederm

Facts for Prelims (FFP) Source: TH  Context: The Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has received approval from the Central Drugs Standard Control Organisation (CDSCO) for its advanced wound care product called Cholederm.   About Cholederm: It is a Class D medical device made from the extracellular matrix of a pig’s …

CDSCO

  Source: FE  Context: Central Drugs Standard Control Organisation (CDSCO) has issued an alert listing 48 commonly used medicines, as they failed the latest drug safety alert issued by the drug regulator   About CDSO

[Mission 2023] INSIGHTS DAILY CURRENT AFFAIRS + PIB SUMMARY 27 February 2023

InstaLinks :  help you think beyond the issue but relevant to the issue from UPSC prelims and Mains exam point of view. These linkages provided in this ‘hint’ format help you frame possible questions ina your mind that might arise(or an examiner might imagine) from each current event. InstaLinks also connect every issue to their …